These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8422939

  • 1. Synthesis and binding characteristics of two sulfhydryl-reactive probes for vasopressin receptors.
    Pávó I, Kojro E, Fahrenholz F.
    FEBS Lett; 1993 Jan 18; 316(1):59-62. PubMed ID: 8422939
    [Abstract] [Full Text] [Related]

  • 2. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
    Pena A, Murat B, Trueba M, Ventura MA, Wo NC, Szeto HH, Cheng LL, Stoev S, Guillon G, Manning M.
    J Med Chem; 2007 Feb 22; 50(4):835-47. PubMed ID: 17300166
    [Abstract] [Full Text] [Related]

  • 3. Biotinyl analogues of vasopressin as biologically active probes for vasopressin receptor expression in cultured cells.
    Jans DA, Bergmann L, Peters R, Fahrenholz F.
    J Biol Chem; 1990 Aug 25; 265(24):14599-605. PubMed ID: 2143764
    [Abstract] [Full Text] [Related]

  • 4. [1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors.
    Derick S, Cheng LL, Voirol MJ, Stoev S, Giacomini M, Wo NC, Szeto HH, Ben Mimoun M, Andres M, Gaillard RC, Guillon G, Manning M.
    Endocrinology; 2002 Dec 25; 143(12):4655-64. PubMed ID: 12446593
    [Abstract] [Full Text] [Related]

  • 5. Effect of bacitracin on the degradation of a vasopressin receptor ligand with high affinity for the V1 and V2 vasopressin isoreceptors.
    Hocher B, Dürr JA, Hensen J.
    Eur J Clin Chem Clin Biochem; 1994 Feb 25; 32(2):61-4. PubMed ID: 8003578
    [Abstract] [Full Text] [Related]

  • 6. Molecular cloning and functional characterization of V2 [8-lysine] vasopressin and oxytocin receptors from a pig kidney cell line.
    Gorbulev V, Büchner H, Akhundova A, Fahrenholz F.
    Eur J Biochem; 1993 Jul 01; 215(1):1-7. PubMed ID: 8393786
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.
    Guillon G, Pena A, Murat B, Derick S, Trueba M, Ventura MA, Szeto HH, Wo N, Stoev S, Cheng LL, Manning M.
    J Pept Sci; 2006 Mar 01; 12(3):190-8. PubMed ID: 16130178
    [Abstract] [Full Text] [Related]

  • 10. The synthesis and biological activity of four novel fluorescent vasopressin analogs.
    Lutz WH, Londowski JM, Kumar R.
    J Biol Chem; 1990 Mar 15; 265(8):4657-63. PubMed ID: 2155234
    [Abstract] [Full Text] [Related]

  • 11. Lateral mobility of the antagonist-occupied V2 vasopressin receptor in membranes of renal epithelial cells.
    Pavo I, Jans DA, Peters R, Penke B, Fahrenholz F.
    Biochim Biophys Acta; 1994 Sep 08; 1223(2):240-6. PubMed ID: 8086494
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological and physiological characterization of d[Leu4, Lys8]vasopressin, the first V1b-selective agonist for rat vasopressin/oxytocin receptors.
    Pena A, Murat B, Trueba M, Ventura MA, Bertrand G, Cheng LL, Stoev S, Szeto HH, Wo N, Brossard G, Serradeil-Le Gal C, Manning M, Guillon G.
    Endocrinology; 2007 Sep 08; 148(9):4136-46. PubMed ID: 17495006
    [Abstract] [Full Text] [Related]

  • 13. Photoaffinity labelling of the renal V2 vasopressin receptor. Identification and enrichment of a vasopressin-binding subunit.
    Fahrenholz F, Boer R, Crause P, Tóth MV.
    Eur J Biochem; 1985 Nov 04; 152(3):589-95. PubMed ID: 2996895
    [Abstract] [Full Text] [Related]

  • 14. Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles.
    Maggi M, Kassis S, Malozowski S, Guardabasso V, Rodbard D.
    Proc Natl Acad Sci U S A; 1986 Dec 04; 83(23):8824-8. PubMed ID: 2947237
    [Abstract] [Full Text] [Related]

  • 15. Hydroosmotic activities of arginine-vasopressins modified either in positions 1, 2 and 4 or at N-terminal extensions.
    Bakos P, Shakhmatova EI, Ponec J, Alexandrová M, Lichardus B, Lammek B, Rekowski P, Kupryszewski G.
    Gen Physiol Biophys; 1992 Aug 04; 11(4):359-76. PubMed ID: 1426981
    [Abstract] [Full Text] [Related]

  • 16. Novel ligand specificity of pituitary vasopressin receptors in the rat.
    Antoni FA.
    Neuroendocrinology; 1984 Aug 04; 39(2):186-8. PubMed ID: 6089020
    [Abstract] [Full Text] [Related]

  • 17. Photoaffinity labeling of the V1 vasopressin receptor in plasma membranes from rat liver.
    Boer R, Fahrenholz F.
    J Biol Chem; 1985 Dec 05; 260(28):15051-4. PubMed ID: 2999103
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and biological activity of a biotinylated vasopressin analog.
    Lutz WH, Londowski JM, Kumar R.
    Peptides; 1990 Dec 05; 11(4):687-91. PubMed ID: 2172938
    [Abstract] [Full Text] [Related]

  • 19. Photoreactive neurohypophyseal hormone analogs: effects on transport processes in mammalian and amphibian epithelia.
    Fahrenholz F, Eggena P, Gazis D, Tóth MV, Schwartz IL.
    Endocrinology; 1986 Mar 05; 118(3):1026-31. PubMed ID: 2936596
    [Abstract] [Full Text] [Related]

  • 20. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M, Cheng LL, Stoev S, Bankowski K, Przybyiski J, Klis WA, Sawyer WH, Wo NC, Chan WY.
    J Pept Sci; 1995 Mar 05; 1(1):66-79. PubMed ID: 9222985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.